In most cases, CLN1 disease manifests clinically as infantile NCL (INCL) that is characterized by onset during childhood, at around 6–24 months of age, and has an invariably fatal outcome by 9–13 years of age (Santavuori et al, 1993). This evidence concerns the gene PPT1 and infantile neuronal ceroid lipofuscinosis.